Wells is Chief Scientific Officer of Medicines for Malaria Venture (MMV), Geneva. Prior to joining MMV, Tim was Senior Executive Vice President Research at Serono and brought several innovative molecules into clinical studies. From 1997 to 2007, he worked at the Glaxo Institute for Molecular Biology in Geneva, where he ran Protein Biochemistry, and led the research on chemotactic cytokines. An enzymologist by training, his research interests include protein structure function relationships, and the role of cytokines in controlling host responses. Tim has over 180 scientific publications and several patent applications. He has a PhD in Chemistry from Imperial College, London for Protein Engineering studies on enzyme catalysis, with Sir Alan Fersht. He was awarded a ScD in Biology from the University of Cambridge for his later work on Cytokine Biology, and is a Fellow of the Royal Society of Chemistry, and the UK Academy of Medical Sciences. Wells is Chief Scientific Officer of Medicines for Malaria Venture (MMV), Geneva. Prior to joining MMV, Tim was Senior Executive Vice President Research at Serono and brought several innovative molecules into clinical studies. From 1997 to 2007, he worked at the Glaxo Institute for Molecular Biology in Geneva, where he ran Protein Biochemistry, and led the research on chemotactic cytokines. An enzymologist by training, his research interests include protein structure function relationships, and the role of cytokines in controlling host responses. Tim has over 180 scientific publications and several patent applications. He has a PhD in Chemistry from Imperial College, London for Protein Engineering studies on enzyme catalysis, with Sir Alan Fersht. He was awarded a ScD in Biology from the University of Cambridge for his later work on Cytokine Biology, and is a Fellow of the Royal Society of Chemistry, and the UK Academy of Medical Sciences.

fermentation